MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study

    P.K. Pal, R.M. Naduthota, L. George, K. Jhunjhunwala, J. Saini, R.D. Bharath, A. Lenka, R. Yadav (Bangalore, India)

    Objective: To determine the gray matter (GM) changes in different clinical stages of Parkinson's disease (PD) using Voxel Based Morphometry (VBM). Background: PD is a…
  • 2016 International Congress

    Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes

    T. Toomsoo, A.H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)

    Objective: To evaluate substantia nigra hyperechogenicity (SN+) with transcranial sonography (TCS) in different PD motor subtypes. Background: Parkinson´s disease (PD) patients display a range of…
  • 2016 International Congress

    Brain mechanisms underlying visual processing in Parkinson’s disease

    I. Rektorova, N. Elfmarkova, M. Gajdos, R. Marecek, S. Rapcsak (Brno, Czech Republic)

    Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…
  • 2016 International Congress

    Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals

    M. Chaturvedi, F. Hatz, U. Gschwandtner, V. Roth, P. Fuhr (Basel, Switzerland)

    Objective: To evaluate QEEG measures for classification of Parkinson's disease(PD) patients and healthy individuals, and eventually develop a pre-clinical composite biomarker to identify patients with…
  • 2016 International Congress

    Does dopamine affect the selection of stepping actions in PD?

    E. Mallia, C. Stummer, J. Rothwell, B.R. Bloem, V. Weerdesteyn (London, United Kingdom)

    Objective: To compare the selection of stepping actions during a probabilistic reaction time task in the ON state with the OFF state in people with…
  • 2016 International Congress

    The patient’s perspective: The effect of dopamine on Parkinson symptoms

    H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

    Objective: To investigate the correlation between patient-based vs. clinician-based L-Dopa effects on PD symptoms in tremor-dominant patients. Background: Medication adjustments are often solely based on…
  • 2016 International Congress

    Assessment of brainstem function with blink reflex variations in Parkinson’s disease

    D. Weise, C. Pargac, J.J. Rumpf, C. Fricke, J. Classen (Leipzig, Germany)

    Objective: To assess the brainstem function with different variations of blink reflex studies in Parkinson's disease (PD). Background: Although PD presents principally as a movement…
  • 2016 International Congress

    FYN expression is associated with regulatory region genetic variation

    L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

    Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation…
  • 2016 International Congress

    Comparison of the utility of three cognitive scales for MDS Level-I diagnosis of mild cognitive impairment in Parkinson’s disease: MoCA, PD-CRS and ACE-III

    R. Fernandez-Bobadilla, J. Pagonabarraga, J.A. Matias-Guiu, S. Martínez-Horta, A. Horta-Barba, J. Marin-Lahoz, J. Perez-Perez, B. Pascual-Sedano, H. Bejr-Kasem, A. Campolongo, J. Kulisevsky (Barcelona, Spain)

    Objective: To compare the utility for detecting Mild Cognitive Impairment in Parkinson's disease (PD-MCI) of three abbreviated global scales: the Montreal Cognitive Assessment (MoCA), the…
  • 2016 International Congress

    Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease

    J.J. Lee, Y. Lee, S.J. Chung, Y.H. Sohn, P.H. Lee (Seoul, Korea)

    Objective: To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD)…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley